{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:06:48Z","timestamp":1761919608000},"reference-count":71,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mechanisms of Ageing and Development"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.mad.2012.05.007","type":"journal-article","created":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T05:30:23Z","timestamp":1339219823000},"page":"479-488","source":"Crossref","is-referenced-by-count":9,"title":["Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: Evidence for premature aging of the myeloid compartment"],"prefix":"10.1016","volume":"133","author":[{"given":"Chiara","family":"Lobetti-Bodoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Genuardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Passera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Bernocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Sia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Grignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cris\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigia","family":"Monitillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Rocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Drandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Giai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Zanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Boi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Isaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Barbero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monia","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Abruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Pini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Pregno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Carlo-Stella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Boccadoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ladetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mad.2012.05.007_bib0005","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cncr.22699","article-title":"Characterization of Ph-negative abnormal clones emerging during imatinib therapy","volume":"109","author":"Abruzzese","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.mad.2012.05.007_bib0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bmt.1702144","article-title":"Shortening of telomeres in recipients of both autologous and allogenic hematopoietic stem cell transplantation","volume":"25","author":"Akiyama","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.mad.2012.05.007_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1152\/physrev.00026.2007","article-title":"Telomeres and aging","volume":"88","author":"Aubert","year":"2008","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.mad.2012.05.007_bib0020","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.mad.2012.05.007_bib0025","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood.V91.10.3582","article-title":"Progressive telomere shortening in aplastic anemia","volume":"91","author":"Ball","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg2047","article-title":"The epigenetic regulation of mammalian telomeres","volume":"8","author":"Blasco Mar\u00eda","year":"2007","journal-title":"Nature Reviews: Genetics"},{"key":"10.1016\/j.mad.2012.05.007_bib0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V96.1.358","article-title":"Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase","volume":"96","author":"Boultwood","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/intimm\/dxp027","article-title":"The effects of c-Abl mutation on developing B cell differentiation and survival","volume":"2","author":"Brightbill","year":"2009","journal-title":"International Immunology"},{"key":"10.1016\/j.mad.2012.05.007_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000279442","article-title":"Nomenclature evolution: changes in the ISCN from the 2005 to the 2009 edition","volume":"127","author":"Brothman","year":"2009","journal-title":"Cytogenetic and Genome Research"},{"key":"10.1016\/j.mad.2012.05.007_bib0050","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V97.4.895","article-title":"Telomere length in leukocyte subpopulations of patients with aplastic anemia","volume":"97","author":"Br\u00fcmmendorf","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2002-08-2557","article-title":"Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia","volume":"101","author":"Br\u00fcmmendorf","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0060","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/sj.leu.2404339","article-title":"Telomere length dynamics in normal hematopoiesis and in disease states characterized by increased stem cell turnover","volume":"20","author":"Br\u00fcmmendorf","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.mad.2012.05.007_bib0065","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","article-title":"Emergence of clonal cytogenetic abnormalities in Ph-cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority","volume":"101","author":"Bumm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0070","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/leu.2010.123","article-title":"Clonal chromosomal abnormalities in CD34+\/CD38\u2212 hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors","volume":"24","author":"Bumm","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.mad.2012.05.007_bib0075","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood-2007-08-019729","article-title":"Telomere maintenance and human bone marrow failure","volume":"111","author":"Calado","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0080","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1002\/cncr.26062","article-title":"Practical management of patients with chronic myeloid leukemia","volume":"117","author":"Cervantes","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.mad.2012.05.007_bib0085","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V79.4.997.bloodjournal794997","article-title":"Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia","volume":"79","author":"Claxton","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","article-title":"Cellular senescence in cancer and aging","volume":"130","author":"Collado","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.mad.2012.05.007_bib0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1034\/j.1600-0609.2003.00157.x","article-title":"Telomere shortening in patients with plasma cell disorders","volume":"71","author":"Cottliar","year":"2003","journal-title":"European Journal of Haematology"},{"key":"10.1016\/j.mad.2012.05.007_bib0100","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.1170633","article-title":"How telomeres solve the end-protection problem","volume":"326","author":"de Lange","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.mad.2012.05.007_bib0105","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/cncr.22936","article-title":"The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells","volume":"110","author":"Deininger","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.mad.2012.05.007_bib0110","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1634\/stemcells.2007-0057","article-title":"Concise review: telomere biology in normal and leukemic hematopoietic stem cells","volume":"25","author":"Drummond","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.mad.2012.05.007_bib0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cancergencyto.2009.01.001","article-title":"Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation","volume":"190","author":"Erdag","year":"2009","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1016\/j.mad.2012.05.007_bib0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.leu.2402038","volume":"15","author":"Ferrero","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.mad.2012.05.007_bib0125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/jhh.2011.57","article-title":"Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study","volume":"25","author":"Fyhrquist","year":"2011","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/j.mad.2012.05.007_bib0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2011.06.004","article-title":"Telomere biology in hematopoiesis and stem cell transplantation","volume":"25","author":"Gadalla","year":"2011","journal-title":"Blood Reviews"},{"issue":"s3","key":"10.1016\/j.mad.2012.05.007_bib0135","first-page":"34","article-title":"Telomere length measurement in the clinically oriented research setting: a comparison between southern blot (SB), real time quantitative pcr (RQ-PCR) and flow-fish (FF)","volume":"96","author":"Genuardi","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.mad.2012.05.007_bib0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.beha.2009.08.001","article-title":"Treatment strategies for CML","volume":"22","author":"Goldman","year":"2009","journal-title":"Best Practice & Research: Clinical Haematology"},{"key":"10.1016\/j.mad.2012.05.007_bib0145","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.4161\/cc.9.20.13577","article-title":"ROS induced DNA damage and checkpoint responses: influences on aging?","volume":"9","author":"Guachalla","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mad.2012.05.007_bib0150","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1200\/JCO.2003.06.018","article-title":"Role of telomeres and telomerase in the pathogenesis of human cancer","volume":"21","author":"Hahn","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.mad.2012.05.007_bib0155","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomere shorten during ageing of human fibroblast","volume":"31","author":"Harley","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.mad.2012.05.007_bib0160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.2009.04565.x","article-title":"Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies","volume":"1176","author":"Hills","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.mad.2012.05.007_bib0165","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1182\/blood-2009-01-198374","article-title":"Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA)","volume":"113","author":"Hills","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.exger.2009.02.006","article-title":"Telomere length-heterogeneity among myeloid cells is a predictor for chronological ageing","volume":"44","author":"Hoffman","year":"2009","journal-title":"Experimental Gerontology"},{"key":"10.1016\/j.mad.2012.05.007_bib0175","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-01-070045","article-title":"Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"110","author":"Jabbour","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/gerona\/63.5.467","article-title":"A percentage analysis of the telomere length in Parkinson's disease patients","volume":"63","author":"Jing","year":"2008","journal-title":"The Journals of Gerontology Series A: Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.mad.2012.05.007_bib0185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.mad.2012.05.007_bib0190","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cncr.24066","article-title":"Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase","volume":"115","author":"Kantarjian","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.mad.2012.05.007_bib0195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hon.901","article-title":"Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy","volume":"27","author":"Keller","year":"2009","journal-title":"Hematological Oncology"},{"key":"10.1016\/j.mad.2012.05.007_bib0200","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","article-title":"Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia","volume":"108","author":"Kovitz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0205","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1182\/blood-2003-12-4412","article-title":"Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders","volume":"103","author":"Ladetto","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0210","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1182\/blood-2010-02-272104","article-title":"Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis","volume":"116","author":"Lin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/hon.937","article-title":"Telomeres and telomerase in normal and malignant B-cells","volume":"28","author":"Lobetti-Bodoni","year":"2010","journal-title":"Hematological Oncology"},{"key":"10.1016\/j.mad.2012.05.007_bib0220","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V99.9.3129","article-title":"Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia","volume":"99","author":"Maciejewski","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0225","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukemia who have maintained complete molecular remission for at least 2 years: the prospective multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.mad.2012.05.007_bib0230","series-title":"Multivariate Analysis","author":"Mardia","year":"1979"},{"key":"10.1016\/j.mad.2012.05.007_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc3025","article-title":"Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins","volume":"11","author":"Mart\u00ednez","year":"2011","journal-title":"Nature Reviews: Cancer"},{"key":"10.1016\/j.mad.2012.05.007_bib0240","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cncr.11729","article-title":"Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase","volume":"98","author":"Medina","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.mad.2012.05.007_bib0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exphem.2009.10.005","article-title":"Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinib","volume":"38","author":"Mor-Tzuntz","year":"2010","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.mad.2012.05.007_bib0250","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ajh.20859","article-title":"Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome","volume":"82","author":"Navarro","year":"2007","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.mad.2012.05.007_bib0255","doi-asserted-by":"crossref","first-page":"13782","DOI":"10.1073\/pnas.94.25.13782","article-title":"In vivo telomere dynamics of human hematopoietic stem cells","volume":"94","author":"Notaro","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.mad.2012.05.007_bib0260","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.mad.2012.05.007_bib0265","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.leukres.2009.08.032","article-title":"Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib","volume":"34","author":"Paquette","year":"2010","journal-title":"Leukemia Research"},{"key":"10.1016\/j.mad.2012.05.007_bib0270","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1093\/nar\/gkm893","article-title":"DNA damage in telomeres and mitochondria during cellular senescence: is there a connection?","volume":"35","author":"Passos","year":"2007","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.mad.2012.05.007_bib0275","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1002\/cncr.24432","article-title":"Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure","volume":"115","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.mad.2012.05.007_bib0280","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.leu.2403652","article-title":"Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF","volume":"19","author":"Ricca","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.mad.2012.05.007_bib0285","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1365-2141.2000.01970.x","article-title":"Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns","volume":"109","author":"Robertson","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.mad.2012.05.007_bib0290","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.exphem.2006.12.006","article-title":"Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir","volume":"35","author":"Rocci","year":"2007","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.mad.2012.05.007_bib0295","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2008.399","article-title":"Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia","volume":"23","author":"Rossi","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.mad.2012.05.007_bib0300","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm2241","article-title":"How stem cells age and why this makes us grow old","volume":"8","author":"Sharpless","year":"2007","journal-title":"Nature Reviews: Molecular Cell Biology"},{"key":"10.1016\/j.mad.2012.05.007_bib0305","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0950-3536(87)80032-X","article-title":"Prognosis in chronic myeloid leukaemia: biology of the disease vs. treatment","volume":"1","author":"Sokal","year":"1987","journal-title":"Bailliere's Clinical Haematology"},{"key":"10.1016\/j.mad.2012.05.007_bib0310","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Seminars in Radiation Oncology"},{"key":"10.1016\/j.mad.2012.05.007_bib0315","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.bjc.6602592","article-title":"Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines","volume":"92","author":"Uziel","year":"2005","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.mad.2012.05.007_bib0320","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4161\/epi.6.9.16845","article-title":"On the chromatin structure of eukaryotic telomeres","volume":"6","author":"Vaquero-Sedas","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.mad.2012.05.007_bib0325","doi-asserted-by":"crossref","first-page":"9857","DOI":"10.1073\/pnas.91.21.9857","article-title":"Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age","volume":"91","author":"Vaziri","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.mad.2012.05.007_bib0330","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00109-009-0509-5","article-title":"Role of telomere dysfunction in aging and its detection by biomarkers","volume":"87","author":"von Figura","year":"2009","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.mad.2012.05.007_bib0335","doi-asserted-by":"crossref","first-page":"e5846","DOI":"10.1371\/journal.pone.0005846","article-title":"Agin and replicative senescence have related effects on human stem and progenitors cells","volume":"9","author":"Wagner","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mad.2012.05.007_bib0340","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0140-6736(97)08256-1","article-title":"Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants","volume":"351","author":"Wynn","year":"1998","journal-title":"The Lancet"},{"key":"10.1016\/j.mad.2012.05.007_bib0345","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1182\/blood-2006-07-035089","article-title":"Functional characterization of natural telomerase mutations found in patients with hematologic disorders","volume":"109","author":"Xin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.mad.2012.05.007_bib0350","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.neurobiolaging.2009.12.006","article-title":"Telomere length and cognitive function in community-dwelling elders: findings from the Health ABC Study","volume":"32","author":"Yaffe","year":"2011","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.mad.2012.05.007_bib0355","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1634\/stemcells.22-5-741","article-title":"Effects of telomerase modulation in human hematopoietic progenitor cells","volume":"22","author":"Zimmermann","year":"2004","journal-title":"Stem Cells"}],"container-title":["Mechanisms of Ageing and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637412001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637412001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T18:19:59Z","timestamp":1594232399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0047637412001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0047637412001017"],"URL":"https:\/\/doi.org\/10.1016\/j.mad.2012.05.007","relation":{},"ISSN":["0047-6374"],"issn-type":[{"value":"0047-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}